1-Arylsulfonyl-5,5-dimethylimidazolidine-2,4-diones (3a-d) were prepared by the rearrangement of 3-arylsulfonyl-5,5-dimethylimidazolidine-2,4-diones (2a-d). Compounds (2a-d) were in turn synthesized by the reaction of arylsulfonyl chlorides with 5,5-dimethylimidazolidine-2,4-dione. All the synthesized compounds were characterized by modern spectroscopic techniques. Two of the synthesized compounds, (2a) and (3a), proved to be the stimulators of insulin release when used at concentrations of 100 µM.